EU regulators approve Sanofi, Regeneron's Dupixent for adolescent cases

The Dupixent product developed by French healthcare company Sanofi and its U.S. partner Regeneron has won approval in Europe for adolescents with moderate-to-severe atopic dermatitis, the companies said on Tuesday.

from Reuters: Health News https://ift.tt/2GOYxJc
via IFTTT